Operating Company Healthcare

Danforth Health

Waltham, Massachusetts, United States

Formerly known as Danforth Advisors, Danforth Advisors LLC, Danforth Advisors, LLC

Danforth Health integrates strategy and execution to empower innovation and accelerate value creation for life science companies from discovery through launch, providing cross-functional support across business operations, asset development, regulatory, clinical operations, and commercialization.

Focus Areas
Drug development consulting, Clinical operations consulting, Regulatory and CMC consulting

Tracked deals

7

7 tracked deals across 2023-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

4 buyout · 3 addon

Danforth Health Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for Danforth Health. 2 2023 3 2024 1 2025 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Danforth Health, Inc.
    Target
    Ambit RD, Inc.
    Seller
    Clearsight Advisors, Inc. (exclusive sell-side advisor)
    Type
    Addon

    Danforth Health, Inc., a portfolio company of Avesi Partners, acquired Ambit RD, Inc. Ambit is a technology-enabled solutions provider focused on serving rare and specialty biopharma markets with commercial strategy, advanced analytics, and patient identification solutions.

  • Buyer
    Danforth Advisors, LLC
    Target
    PharmaDirections, Inc.
    Type
    Addon

    Danforth Advisors, a PE-backed life sciences advisory platform, has acquired PharmaDirections, a virtual drug development partner. The acquisition adds more than 150 specialists and expands Danforth's integrated capabilities across discovery, non-clinical and clinical development, CMC, regulatory strategy, and program and alliance management.

  • Buyer
    Danforth Advisors, LLC
    Target
    VPMR, LLC
    Type
    Buyout

    Danforth Advisors, a life-science strategic and operational advisory firm, acquired VPMR, a full-service global market research firm serving life science and healthcare clients. The acquisition expands Danforth’s commercial readiness and market research capabilities; Allison Fuller will remain President of VPMR.

  • Buyer
    Danforth Advisors, LLC
    Target
    Advyzom, LLC
    Type
    Buyout

    Danforth Advisors has acquired Advyzom, a New Jersey–based regulatory affairs consultancy of approximately 30 specialists, expanding Danforth's clinical and regulatory capabilities to offer a comprehensive suite of services for life science companies. The acquisition integrates Advyzom's regulatory strategy, FDA liaison, medical writing, and submissions expertise into Danforth's platform to better support clients across development, approval, and market entry.

  • Buyer
    Danforth Advisors, LLC
    Target
    BW Health Group
    Type
    Addon

    Danforth Advisors has acquired BW Health Group, a commercialization and product-launch services platform serving small- and mid-sized life science companies. The deal adds commercial readiness, launch planning and biopharma marketing capabilities (Benchworks and BW Consulting) to Danforth's integrated life-science advisory and operational services offering.

  • Buyer
    Danforth Advisors, LLC
    Target
    Elite BioPharma Consulting, Inc.
    Type
    Buyout

    Danforth Advisors has acquired Elite BioPharma Consulting to expand its Development Strategy & Operations (DS&O) practice, adding clinical development operations, project and trial management, clinical monitoring, program management, regulatory affairs, and medical writing capabilities. The founders of Elite will continue to lead the team as Danforth integrates Elite's expertise into its variable resource model for life science companies.

  • Buyer
    Danforth Advisors, LLC
    Target
    Argot Partners, LLC
    Type
    Buyout

    Danforth Advisors, a provider of outsourced corporate and clinical business functions for the life sciences, has acquired Argot Partners, a strategic communications and investor-relations consultancy focused on life sciences. The acquisition expands Danforth's integrated service offering to include strategic communications; Argot's founders will continue to lead the firm.

Related Acquisition Pages

Selling a company? Get in front of buyers like Danforth Health

Turn tracked acquisition activity into an outreach-ready buyer list.